Phase 1 safety, pharmacokinetic and pharmacodynamic study of fadraciclib (CYC065), a cyclin dependent kinase inhibitor, in patients with advanced cancers (NCT02552953). (October 2020)

Record Type:: Journal Article
Title:: Phase 1 safety, pharmacokinetic and pharmacodynamic study of fadraciclib (CYC065), a cyclin dependent kinase inhibitor, in patients with advanced cancers (NCT02552953). (October 2020)
Main Title:: Phase 1 safety, pharmacokinetic and pharmacodynamic study of fadraciclib (CYC065), a cyclin dependent kinase inhibitor, in patients with advanced cancers (NCT02552953)
Authors:: Do, K.T.
Frej, K.
Bhushan, K.
Pruitt-Thompson, S.
Zheleva, D.
Blake, D.
Chiao, J.
Shapiro, G.I.
Abstract:
Is Part Of:: European journal of cancer. Volume 138(2020)Supplement 2
Journal:: European journal of cancer
Issue:: Volume 138(2020)Supplement 2
Issue Display:: Volume 138, Issue 1 (2020)
Year:: 2020
Volume:: 138
Issue:: 1
Issue Sort Value:: 2020-0138-0001-0000
Page Start:: S7
Page End:
Publication Date:: 2020-10
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(20)31086-8 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 15526.xml